<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00713167</url>
  </required_header>
  <id_info>
    <org_study_id>SBMU 87-01-106-5694</org_study_id>
    <nct_id>NCT00713167</nct_id>
  </id_info>
  <brief_title>The Efficacy of Red Grape Seed Extract on Lipid Profile and Oxidized Low-Density Lipoprotein (OX-LDL)</brief_title>
  <acronym>GSE</acronym>
  <official_title>Randomized, Cross-Over, Double Blind, Placebo-Controlled Study of Grape Seed Extract in Treating Patients With Mild Hyperlipidemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shahid Beheshti University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tabriz University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shahid Beheshti University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Antioxidants are potent scavengers of free radicals and serve as inhibitors of neoplastic
      processes. A large number of synthetic and natural antioxidants are known to induce
      beneficial effects on human health and disease prevention. Cardioprotective ability of grape
      seed extract polyphenols (GSEP) was studied in animals and humans. It has been suggested that
      grape seed proanthocyanidins have cardioprotective effects against reperfusion-induced injury
      of free radicals after ischemia. In another study, it is suggested that proanthocyanidins,
      the major polyphenols in red wine, might trap reactive oxygen species in aqueous series such
      as plasma and interstitial fluid of the arterial wall; thereby inhibiting oxidation of
      low-density lipoprotein (LDL) and showing an antiatherosclerotic activity. The only human
      model study designed to evaluate the effect of a standardized formulation of a GSEP
      (leucoselect-phytosome [LP]) on the susceptibility of LDL to oxidation in a group of heavy
      smokers, revealed that the antioxidant potential of GSEP may be effective in oxidative stress
      (smoking); however more investigational data are needed before wider use in clinical
      settings. Based on these observations, the investigators decided to evaluate the effect of
      GSEP in reducing OX-LDL in patients diagnosed with mild hyperlipidemia.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Actual">February 2009</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>OX-LDL</measure>
    <time_frame>8 weeks -{45 days wash out, crossed }- 8 weeks after crossed</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>LDL</measure>
    <time_frame>8 weeks -{45 days wash out, crossed }- 8 weeks after crossed</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HDL</measure>
    <time_frame>8 weeks -{45 days wash out, crossed }- 8 weeks after crossed</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>8 weeks -{45 days wash out, crossed }- 8 weeks after crossed</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Triglyceride</measure>
    <time_frame>8 weeks -{45 days wash out, crossed }- 8 weeks after crossed</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Cholesterol</measure>
    <time_frame>8 weeks -{45 days wash out, crossed }- 8 weeks after crossed</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Mass Index</measure>
    <time_frame>8 weeks -{45 days wash out, crossed }- 8 weeks after crossed</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LDL/HDL</measure>
    <time_frame>8 weeks- {45 days wash out, crossed }- 8 weeks after crossed</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">55</enrollment>
  <condition>Hyperlipidemia</condition>
  <arm_group>
    <arm_group_label>Grape Seed Extract</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Enrolled patients who are randomly assigned to receive Grape Seed Extract capsules</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo enrolled patients who are randomly assigned to receive placebo of Grape Seed Extract</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Grape Seed Extract (Vitagrape)</intervention_name>
    <description>Drug {Each Containing: Grape Seed Extract100 mg +...}
1 capsule twice daily for 2 months</description>
    <arm_group_label>Grape Seed Extract</arm_group_label>
    <other_name>Vitagrape</other_name>
    <other_name>Iran Ministry of Health Registration Number: 5/92/43198</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo of Grape Seed Extract</intervention_name>
    <description>Placebo {Each Containing: Gelatin 17mg + Cellulose Microcrystalline (Avicel) 67 mg + Dicalcium Phosphate 216mg}
1 capsule twice daily for 2 months</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Triglyceride &gt; 150 mg/dl

          2. Total Cholesterol &gt; 200 mg/dl

        Exclusion Criteria:

          1. Severe hyperlipidemia (Triglyceride &gt; 300 mg/dl,Total Cholesterol &gt; 250 mg/dl)

          2. Usage of antilipid drugs

          3. Herbivore Diet

          4. Alcoholism

          5. Heart failure

          6. Known cases of any malignancy

          7. BMI &gt; 30 kg/M2

          8. Chronic Hepatic Diseases

          9. Smoking

         10. Chronic Renal Failure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maryam Keshtkar-Jahromi, MD,</last_name>
    <role>Study Director</role>
    <affiliation>Shahid Beheshti University (MC)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hassan Argani, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Shahid Beheshti University (MC)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Abbas Delazar, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tabriz University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ali Eskandari, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shahid Beheshti University (MC)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sharareh Gholamin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shahid Beheshti University (MC)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Seyed Mostafa Razavi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shahid Beheshti University (MC)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ghorbanihaghjo</name>
      <address>
        <city>Tabriz</city>
        <state>East Azarbayejan</state>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maryam</name>
      <address>
        <city>Tehran</city>
        <zip>19814</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <reference>
    <citation>Bagchi D, Bagchi M, Stohs SJ, Das DK, Ray SD, Kuszynski CA, Joshi SS, Pruess HG. Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention. Toxicology. 2000 Aug 7;148(2-3):187-97.</citation>
    <PMID>10962138</PMID>
  </reference>
  <reference>
    <citation>Bagchi D, Sen CK, Ray SD, Das DK, Bagchi M, Preuss HG, Vinson JA. Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract. Mutat Res. 2003 Feb-Mar;523-524:87-97. Review.</citation>
    <PMID>12628506</PMID>
  </reference>
  <reference>
    <citation>Pataki T, Bak I, Kovacs P, Bagchi D, Das DK, Tosaki A. Grape seed proanthocyanidins improved cardiac recovery during reperfusion after ischemia in isolated rat hearts. Am J Clin Nutr. 2002 May;75(5):894-9.</citation>
    <PMID>11976164</PMID>
  </reference>
  <reference>
    <citation>Joshi SS, Kuszynski CA, Bagchi D. The cellular and molecular basis of health benefits of grape seed proanthocyanidin extract. Curr Pharm Biotechnol. 2001 Jun;2(2):187-200.</citation>
    <PMID>11480422</PMID>
  </reference>
  <reference>
    <citation>Bagchi D, Garg A, Krohn RL, Bagchi M, Bagchi DJ, Balmoori J, Stohs SJ. Protective effects of grape seed proanthocyanidins and selected antioxidants against TPA-induced hepatic and brain lipid peroxidation and DNA fragmentation, and peritoneal macrophage activation in mice. Gen Pharmacol. 1998 May;30(5):771-6.</citation>
    <PMID>9559333</PMID>
  </reference>
  <reference>
    <citation>Yamakoshi J, Kataoka S, Koga T, Ariga T. Proanthocyanidin-rich extract from grape seeds attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Atherosclerosis. 1999 Jan;142(1):139-49.</citation>
    <PMID>9920515</PMID>
  </reference>
  <reference>
    <citation>Zhang FL, Gao HQ, Wu JM, Ma YB, You BA, Li BY, Xuan JH. Selective inhibition by grape seed proanthocyanidin extracts of cell adhesion molecule expression induced by advanced glycation end products in endothelial cells. J Cardiovasc Pharmacol. 2006 Aug;48(2):47-53.</citation>
    <PMID>16954821</PMID>
  </reference>
  <reference>
    <citation>Vigna GB, Costantini F, Aldini G, Carini M, Catapano A, Schena F, Tangerini A, Zanca R, Bombardelli E, Morazzoni P, Mezzetti A, Fellin R, Maffei Facino R. Effect of a standardized grape seed extract on low-density lipoprotein susceptibility to oxidation in heavy smokers. Metabolism. 2003 Oct;52(10):1250-7.</citation>
    <PMID>14564675</PMID>
  </reference>
  <verification_date>May 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 8, 2008</study_first_submitted>
  <study_first_submitted_qc>July 8, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 11, 2008</study_first_posted>
  <last_update_submitted>May 20, 2009</last_update_submitted>
  <last_update_submitted_qc>May 20, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 21, 2009</last_update_posted>
  <responsible_party>
    <name_title>Maryam Keshtkar Jahromi</name_title>
    <organization>Shahid Beheshti University (MC)</organization>
  </responsible_party>
  <keyword>Grape Seed Extract</keyword>
  <keyword>Hyperlipidemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperlipidemias</mesh_term>
    <mesh_term>Hyperlipoproteinemias</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Grape Seed Extract</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

